Covid-19, the new coronavirus: an emergency alert for the main public health prevention strategies

• Autor(a) principal: Silva, Agne Clecia Reis
• Data de Publicação: 2020
• Outros Autores: Jesus, Taylaine Santos de, Santos, Sergio de Santana, Santos, Gilderlaine de Jesus, Rodrigues, Wellington Pereira
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Scire Salutis
• Texto Completo: https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2020.002.0004
• topic: Coronavírus; Saúde Pública; Prevenção; Coronavirus; Public health; Prevention

Introduction: The new Coronavirus, a type of virus, already identified, as an etiological agent that triggers an alarming outbreak of a respiratory disease causing pneumonia of unknown origin, which triggered the primary spread in the city of Wuhan, located in China. Objective: To know the possible forms of guidance for the National Health Surveillance System agencies in partnership with the Primary Health Care services, to act in the identification of cases, carrying out notifications and in the referencing of suspected cases due to infection due to the Coronavirus. Method: For the development of this study, a literature review was carried out, characterized in the analysis of the information available at a given moment and about a specific problem. Thus, the present study is descriptive in nature, with a qualitative approach. The search for articles took place in the Scientific Electronic Library Online (SciELO), Virtual Health Library (VHL) and Google Scholar databases. For the inclusion criteria used, articles published between the years 2017 to 2020, described in Portuguese, that presented studies on the outbreak of coronavirus disease worldwide were selected. Results: In 2002 and 2003 China had about 8,096 cases in several countries and with a total of 774 deaths, with a lethality rate of 9.5%, while MERS-CoV. In 2012, this new episode was due to the MERS-CoV that caused the outbreaks that occurred in the Middle East, in which 2,494 cases were recorded in 27 countries and this time with 858 deaths and a fatality rate of 34%. Thus, in laboratory evaluations they were in an age group above 50 years and they presented fever (> 37.8), cough, respiratory symptoms, runny nose, muscle pain, mental confusion, headache, sore throat, myalgia / arthralgia, enlarged lymph nodes, dehydration, lack of appetite, diarrhea, nausea and vomiting, presence of spots on the skin. Conclusion: The accelerated arrival of the new virus calls into question the structure of health and epidemiological surveillance existing in the country, especially at a time when there were cuts in investments in the Unified Health System (SUS) and in research, weakening the capacity for early detection and response even to your treatment.